Literature DB >> 11596907

Plague and other human infections caused by Yersinia species.

M Putzker1, H Sauer, D Sobe.   

Abstract

With an estimated 100 million victims, pandemically and epidemically occurring plague has been looked upon as a classical scourge of mankind during the last two millenia. Without treatment at least 50% of the affected individuals die from infection with Yersinia pestis, a bacterium belonging to the family of Enterobacteriaceae. The disease takes a fulminant course. After an incubation period of 2-6 days, bubonic plague primarily attacks one group of lymph nodes. The onset of pulmonic plague, transmitted by droplet infection, takes place within several hours and causes bronchopneumonia. Early recognition facilitates a promising antibiotic therapy with tetracycline, streptomycin or chloramphenicol. Human beings acquire the bacteria through bites of fleas from domestic rats in densely populated cities of countries with low hygienic standards, or sporadically in the open country from infected wild rodents. Laboratory procedure includes microscopy supplemented by immunofluorescence and cultivation of the bacterium from clinical material. Direct serology and PCR result in a fast detection of specific antigens or nucleotide sequences. Determination of serum antibodies is principally used for epidemiological investigation. Today, physicians in the civilized western world lack experience for the recognition of plague, and analytical techniques for diagnosis are only available in some specialized laboratories. Yersiniosis becomes primarily manifest as gastroenteritis caused by Yersinia enterocolitica or as pseudoappendicitis caused by Yersinia pseudotuberculosis and requires antibiotics only in severe septic cases. Different extraintestinal symptoms may be observed in dependence on the patient's HLA type and gender. The ubiquitous germ is mainly transmitted by the fecal-oral route via infected domestic or farm animals and contaminated food. The relevant virulence factors are encoded on a 70 kB plasmid common to all Yersinia species and strains that are human pathogens. The most important tools for laboratory diagnosis are culture from suitable body fluids and serological detection of specific antibodies. The infection rate among healthy individuals in Europe in terms of percentage of elevated IgA or IgG titers has been quoted to be 3-40% in different investigations but does not significantly correlate to direct bacteriological detection.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11596907

Source DB:  PubMed          Journal:  Clin Lab        ISSN: 1433-6510            Impact factor:   1.138


  10 in total

Review 1.  Yersinia Type III Secretion System Master Regulator LcrF.

Authors:  Leah Schwiesow; Hanh Lam; Petra Dersch; Victoria Auerbuch
Journal:  J Bacteriol       Date:  2015-12-07       Impact factor: 3.490

2.  A mutant with aberrant extracellular LcrV-YscF interactions fails to form pores and translocate Yop effector proteins but retains the ability to trigger Yop secretion in response to host cell contact.

Authors:  Dana E Harmon; Julia L Murphy; Alison J Davis; Joan Mecsas
Journal:  J Bacteriol       Date:  2013-03-08       Impact factor: 3.490

3.  Evaluation of a western blot method for the detection of Yersinia antibodies: evidence of serological cross-reactivity between Yersinia outer membrane proteins and Borrelia burgdorferi.

Authors:  Mindy L Rawlins; Cecilia Gerstner; Harry R Hill; Christine M Litwin
Journal:  Clin Diagn Lab Immunol       Date:  2005-11

4.  Rapid detection and simultaneous antibiotic susceptibility analysis of Yersinia pestis directly from clinical specimens by use of reporter phage.

Authors:  J P Vandamm; C Rajanna; N J Sharp; I J Molineux; D A Schofield
Journal:  J Clin Microbiol       Date:  2014-06-11       Impact factor: 5.948

5.  Yersinia pestis uses the Ail outer membrane protein to recruit vitronectin.

Authors:  Sara Schesser Bartra; Yi Ding; L Miya Fujimoto; Joshua G Ring; Vishal Jain; Sanjay Ram; Francesca M Marassi; Gregory V Plano
Journal:  Microbiology (Reading)       Date:  2015-09-15       Impact factor: 2.777

6.  Identification and characterization of small-molecule inhibitors of Yop translocation in Yersinia pseudotuberculosis.

Authors:  Dana E Harmon; Alison J Davis; Cynthia Castillo; Joan Mecsas
Journal:  Antimicrob Agents Chemother       Date:  2010-05-24       Impact factor: 5.191

7.  Yersinia has a tropism for B and T cell zones of lymph nodes that is independent of the type III secretion system.

Authors:  Joan-Miquel Balada-Llasat; Joan Mecsas
Journal:  PLoS Pathog       Date:  2006-09       Impact factor: 6.823

8.  Growth of Yersinia pseudotuberculosis in human plasma: impacts on virulence and metabolic gene expression.

Authors:  Marie-Laure Rosso; Sylvie Chauvaux; Rodrigue Dessein; Caroline Laurans; Lionel Frangeul; Céline Lacroix; Angèle Schiavo; Marie-Agnès Dillies; Jeannine Foulon; Jean-Yves Coppée; Claudine Médigue; Elisabeth Carniel; Michel Simonet; Michaël Marceau
Journal:  BMC Microbiol       Date:  2008-12-03       Impact factor: 3.605

9.  Genome Scale Analysis Reveals IscR Directly and Indirectly Regulates Virulence Factor Genes in Pathogenic Yersinia.

Authors:  David Balderas; Erin Mettert; Hanh N Lam; Rajdeep Banerjee; Tomas Gverzdys; Pablo Alvarez; Geetha Saarunya; Natasha Tanner; Adam Zoubedi; Yahan Wei; Patricia J Kiley; Victoria Auerbuch
Journal:  mBio       Date:  2021-06-01       Impact factor: 7.867

Review 10.  Type VI Secretion Systems Present New Insights on Pathogenic Yersinia.

Authors:  Xiaobing Yang; Junfeng Pan; Yao Wang; Xihui Shen
Journal:  Front Cell Infect Microbiol       Date:  2018-07-31       Impact factor: 5.293

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.